Bulk Manufacturer of Controlled Substances Application: Euticals Inc., 64510 [2016-22527]
Download as PDF
<![CDATA[
64510
Federal Register / Vol. 81, No. 182 / Tuesday, September 20, 2016 / Notices
Dated: September 12, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
Drug Enforcement Administration
other forms of information technology,
e.g., permitting electronic submission of
responses.
[FR Doc. 2016–22527 Filed 9–19–16; 8:45 am]
DEPARTMENT OF JUSTICE
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a Currently Approved
Collection.
(2) Title of the Form/Collection: SemiAnnual Progress Report for Grantees
from the Tribal Sexual Assault Services
Program.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: 1122–0024.
U.S. Department of Justice, Office on
Violence Against Women.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: The affected public includes
the approximately 15 grantees of the
Tribal Sexual Assault Services Program.
The Sexual Assault Services Program
(SASP), created by the Violence Against
Women Act of 2005 (VAWA 2005), is
the first federal funding stream solely
dedicated to the provision of direct
intervention and related assistance for
victims of sexual assault. The SASP
encompasses four different funding
streams for States and Territories,
Tribes, State Sexual Assault Coalitions,
Tribal Coalitions, and culturally specific
organizations. Overall, the purpose of
SASP is to provide intervention,
advocacy, accompaniment, support
services, and related assistance for
adult, youth, and child victims of sexual
assault, family and household members
of victims, and those collaterally
affected by the sexual assault.
The Tribal SASP supports efforts to
help survivors heal from sexual assault
trauma through direct intervention and
related assistance from social service
organizations such as rape crisis centers
through 24-hour sexual assault hotlines,
crisis intervention, and medical and
criminal justice accompaniment. The
Tribal SASP will support such services
through the establishment,
maintenance, and expansion of rape
crisis centers and other programs and
projects to assist those victimized by
sexual assault.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that it will
take the approximately 15 respondents
(grantees from the Tribal Sexual Assault
Services Program) approximately one
hour to complete a semi-annual progress
report. The semi-annual progress report
is divided into sections that pertain to
the different types of activities in which
grantees may engage. A Tribal SASP
[Docket No. DEA–392]
BILLING CODE 4410–09–P
Bulk Manufacturer of Controlled
Substances Application: Euticals Inc.
DEPARTMENT OF JUSTICE
ACTION:
[OMB Number 1122–0024]
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before November 21, 2016.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on July 4,
2016, Euticals, Inc., 2460 W. Bennett
Street, Springfield, Missouri 65807–
1229 applied to be registered as a bulk
manufacturer the following basic classes
of controlled substances:
SUPPLEMENTARY INFORMATION:
sradovich on DSK3GMQ082PROD with NOTICES
Controlled substance
Schedule
Gamma
Hydroxybutyric
Acid
(2010).
Amphetamine (1100) ....................
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Phenylacetone (8501) ..................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Tapentadol (9780) ........................
I
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution and sale to its
customers.
VerDate Sep<11>2014
17:13 Sep 19, 2016
Jkt 238001
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Currently Approved Collection
Office on Violence Against
Women, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice,
Office on Violence Against Women
(OVW) will be submitting the following
information collection request to the
Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
November 21, 2016.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Cathy Poston, Office on Violence
Against Women, at 202–514–5430 or
Catherine.poston@usdoj.gov.
SUMMARY:
SUPPLEMENTARY INFORMATION:
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 81, Number 182 (Tuesday, September 20, 2016)]
[Notices]
[Page 64510]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22527]
[[Page 64510]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Euticals
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before November 21, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on July
4, 2016, Euticals, Inc., 2460 W. Bennett Street, Springfield, Missouri
65807-1229 applied to be registered as a bulk manufacturer the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)........... I
Amphetamine (1100)......................... II
Lisdexamfetamine (1205).................... II
Methylphenidate (1724)..................... II
Phenylacetone (8501)....................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution and sale to its customers.
Dated: September 12, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-22527 Filed 9-19-16; 8:45 am]
BILLING CODE 4410-09-P
